Myriad Genetics (MYGN)
(Delayed Data from NSDQ)
$18.18 USD
+0.20 (1.11%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $18.17 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/01/2024
Time: -- |
3/2024 | $-0.11 | -19.74% |
Earnings Summary
For their last quarter, Myriad Genetics (MYGN) reported earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This reflects a positive earnings surprise of 100.00%. Look out for MYGN's next earnings release expected on May 01, 2024. For the next earning release, we expect the company to report earnings of -$0.11 per share, reflecting a year-over-year increase of 47.62%.
Earnings History
Price & Consensus
Zacks News for MYGN
Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know
MYGN: What are Zacks experts saying now?
Zacks Private Portfolio Services